Collegium Pharmaceutical, Inc.
COLL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $71 | $239 | $174 | $186 |
| Short-Term Investments | $92 | $72 | $0 | $0 |
| Receivables | $229 | $180 | $183 | $106 |
| Inventory | $36 | $32 | $47 | $17 |
| Other Curr. Assets | $28 | $0 | $0 | $0 |
| Total Curr. Assets | $482 | $538 | $420 | $316 |
| Property Plant & Equip (Net) | $20 | $22 | $26 | $27 |
| Goodwill | $162 | $134 | $134 | $0 |
| Intangibles | $891 | $422 | $567 | $269 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $98 | $26 | $24 | $78 |
| Other NC Assets | $9 | $2 | $3 | $3 |
| Total NC Assets | $1,181 | $606 | $754 | $377 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,664 | $1,143 | $1,174 | $692 |
| Liabilities | – | – | – | – |
| Payables | $4 | $9 | $3 | $4 |
| Short-Term Debt | $65 | $183 | $163 | $48 |
| Tax Payable | $15 | $7 | $4 | $3 |
| Deferred Revenue | $0 | $1 | $0 | $0 |
| Other Curr. Liab. | $8 | $254 | $2 | $1 |
| Total Curr. Liab. | $510 | $458 | $434 | $280 |
| LT Debt | $788 | $484 | $538 | $202 |
| Deferred Rev, NC | $10 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $122 | $0 | $0 | $0 |
| Total NC Liab. | $925 | $490 | $546 | $210 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $7 | $8 | $9 |
| Total Liabilities | $1,435 | $948 | $979 | $489 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$164 | -$233 | -$281 | -$256 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $229 | $195 | $195 | $203 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,664 | $1,143 | $1,174 | $692 |
| Net Debt | $782 | $428 | $527 | $64 |